Airborne Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): What We Know
Jonathan M. Samet, Kimberly A. Prather, Georges C. Benjamin, Seema S. Lakdawala, John J. Lowe, Arthur Reingold, John Volckens, Linsey C. Marr
Abstract
We examine airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) potential using a source-to-dose framework beginning with generation of virus-containing droplets and aerosols and ending with virus deposition in the respiratory tract of susceptible individuals. By addressing 4 critical questions, we identify both gaps in addressing 4 critical questions with answers having policy implications.
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)CoronavirusTransmission (telecommunications)2019-20 coronavirus outbreakRespiratory tractRespiratory systemVirologySars virusSevere acute respiratory syndrome coronavirusAirborne transmissionMedicineVirusSevere acute respiratory syndromeIntensive care medicineInternal medicineComputer scienceDiseaseInfectious disease (medical specialty)TelecommunicationsOutbreakInfection Control and VentilationCOVID-19 and healthcare impactsCOVID-19 impact on air quality